As the US and Europe experiences shortages of crucial medicines, Ben Hargreaves looks at how a once thriving generics industry is now struggling, with many companies seeking to exit the spa
Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that this would disrupt supplies of critical medicines.
